[EverCyte-KY] Announcement of Change in Corporate Director Representatives and Board Composition for Important Subsidiary Taiwan EverCyte
Key facts
- [EverCyte-KY] Announcement of Change in Corporate Director Representatives and Board Composition for Important Subsidiary Taiwan EverCyte
- Taiwan EverCyte, an important subsidiary of EverCyte-KY, has restructured its board to 3 directors and 1 supervisor following amendments to its articles of incorporation.
- Source: PR Times
- Date: May 29, 2026
Direct answer
Taiwan EverCyte, an important subsidiary of EverCyte-KY, has restructured its board to 3 directors and 1 supervisor following amendments to its articles of incorporation.
- Citation
- [EverCyte-KY] Announcement of Change in Corporate Director Representatives and Board Composition for Important Subsidiary Taiwan EverCyte (May 29, 2026), PR Times
- Source
- PR Times
- Date
- May 29, 2026
Taiwan EverCyte, an important subsidiary of EverCyte-KY, has restructured its board to 3 directors and 1 supervisor following amendments to its articles of incorporation.
📋 Article Processing Timeline
- 📰 Published: May 29, 2026 at 09:00
- 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 17:36 (33h 36m after Collected)
1. Date of change: 115/05/29. 2. Personnel type: Corporate Director and Corporate Supervisor. 3. Former representatives: Li Tung-Yang, Hsu Chin-Chen, Cheng Chih-Hui, Huang Yen-Chen, Cheng Shu-Ling, Wu Yu-Mei. 4. Former resumes: Executives and investment managers. 5. New representatives: Lu Kung-Ming, Kuo Hui-Yuan, Chen Jui-Ching, Cheng Chih-Hui. 6. New resumes: Executives and investment managers. 7. Change status: New appointment. 8. Reason for change: Amendment to articles of incorporation, streamlining board to 3 directors and 1 supervisor. 9. Shares held by new appointees: 62,177,650 shares. 10. Effective date: 115/05/29. 11. Other matters: None.
FAQ
What is a Corporate Director in Taiwan?
A legal entity elected as a director, which appoints a representative to perform duties.
What are the key facts in this article?
Taiwan EverCyte, an important subsidiary of EverCyte-KY, has restructured its board to 3 directors and 1 supervisor following amendments to its articles of incorporation.
What is the direct answer?
Taiwan EverCyte, an important subsidiary of EverCyte-KY, has restructured its board to 3 directors and 1 supervisor following amendments to its articles of incorporation.